Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: MediPharm Labs Corp.

Announced that it has paid off the entire remaining convertible debt amount of $2.1 million, leaving ...

LABS.TO : 0.0700 (+7.69%)
MediPharm Labs Announces $2.1M Debt Repayment

/CNW/ - MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health...

LABS.TO : 0.0700 (+7.69%)
Stocks in play: MediPharm Labs Corp.

Announced its financial results for the three months ended June 30, 2024. Adjusted EBITDA proved negative ...

LABS.TO : 0.0700 (+7.69%)
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0518 (+6.15%)
LABS.TO : 0.0700 (+7.69%)
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0518 (+6.15%)
LABS.TO : 0.0700 (+7.69%)
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0518 (+6.15%)
LABS.TO : 0.0700 (+7.69%)
Stocks in play: MediPharm Labs Corp.

Announced it has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the exclusive ...

LABS.TO : 0.0700 (+7.69%)
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in...

MEDIF : 0.0518 (+6.15%)
LABS.TO : 0.0700 (+7.69%)
Stocks in play: MediPharm Labs Corp.

Announced it has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the exclusive ...

LABS.TO : 0.0700 (+7.69%)
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0518 (+6.15%)
LABS.TO : 0.0700 (+7.69%)

Barchart Exclusives

3 Top Dividend Stocks to Buy This September
After today's jumbo rate cut from the Fed, here are three dividend stocks to bolster your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar